Tonawanda, NY – June 1, 2025 – Pine Pharmaceuticals is proud to announce the return of Bup-Lido (Bupivacaine HCl 0.375%–Lidocaine HCl 2%). This ophthalmic solution joins Pine’s trusted product portfolio and reflects the company’s continued dedication to delivering high-quality, ready-to-administer drug products to healthcare professionals nationwide.
Bup-Lido is conveniently packaged in a 5 mL pre-filled syringe and is formulated for room-temperature storage, eliminating the need for refrigeration. With extended dating, Bup-Lido supports better inventory management, helping practices reduce waste, lower costs, and improve operational efficiency.
“Our goal is to deliver solutions that enhance patient care,” said Alfonse J. Muto, Pharm.D. “We’re excited to offer Bup-Lido once again, ensuring providers have reliable access to essential drug products.”
Our dedicated team is available to assist with ordering, making the procurement process seamless and efficient. For more information or to place an order, please contact our team.
About Pine Pharmaceuticals LLC
Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in the preparation of high-quality, ready-to-administer compounds and repackaged products. As a best-in-class partner, Pine Pharmaceuticals is committed to meeting the FDA’s stringent cGMP requirements while supporting hospitals, surgery centers, and practices nationwide. For more information, please visit www.pinepharmaceuticals.com or call 844-218-4138 to learn more about our products and services.
©2025 Pine Pharmaceuticals. All rights reserved.